Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
25.39
-0.50 (-1.93%)
At close: Aug 28, 2025, 4:00 PM
25.50
+0.11 (0.43%)
After-hours: Aug 28, 2025, 4:10 PM EDT
Assembly Biosciences Stock Forecast
Stock Price Forecast
The 3 analysts that cover Assembly Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $38.67, which forecasts a 52.30% increase in the stock price over the next year. The lowest target is $31 and the highest is $50.
Price Target: $38.67 (+52.30%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Assembly Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +96.93% | Aug 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +22.10% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 24, 2024 |
Financial Forecast
Revenue This Year
32.07M
from 28.52M
Increased by 12.44%
Revenue Next Year
20.77M
from 32.07M
Decreased by -35.24%
EPS This Year
-4.97
from -6.69
EPS Next Year
-2.53
from -4.97
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 43.3M | 43.2M | |||
| Avg | 32.1M | 20.8M | |||
| Low | 8.8M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 51.7% | 34.8% | |||
| Avg | 12.4% | -35.2% | |||
| Low | -69.1% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.73 | -2.33 | |||
| Avg | -4.97 | -2.53 | |||
| Low | -6.16 | -2.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.